- Home
- SIBN
SIBN
SI-BONE Inc.
as of 02-20-2026 4:00pm EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 886.9M | IPO Year: | 2018 |
| Target Price: | $25.00 | AVG Volume (30 days): | 415.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | -0.40 | EPS Growth: | 33.63 |
| 52 Week Low/High: | $12.49 - $21.89 | Next Earning Date: | 04-01-2026 |
| Revenue: | $67,301,000 | Revenue Growth: | 21.53% |
| Revenue Growth (this year): | 21.95% | Revenue Growth (next year): | 15.02% |
| P/E Ratio: | -38.83 | Index: | N/A |
| Free Cash Flow: | -22922000.0 | FCF Growth: | N/A |
AI-Powered SIBN Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of SI-BONE Inc. (SIBN)
Other
Avg Cost/Share
$15.39
Shares
21,049
Total Value
$324,203.85
Owned After
257,626
Chief Financial Officer
Avg Cost/Share
$15.37
Shares
21,528
Total Value
$330,981.88
Owned After
266,466
Chief Executive Officer
Avg Cost/Share
$15.32
Shares
93,475
Total Value
$1,432,121.59
Owned After
559,729
SVP, Ops & Adm/Chief Legal Ofr
Avg Cost/Share
$15.35
Shares
20,756
Total Value
$318,642.34
Owned After
304,174
Director
Avg Cost/Share
$16.42
Shares
337
Total Value
$5,532.09
Owned After
9,970
SEC Form 4
Director
Avg Cost/Share
$21.28
Shares
20,000
Total Value
$425,506.00
Owned After
9,970
SEC Form 4
President, Commercial Ops
Avg Cost/Share
$19.62
Shares
3,677
Total Value
$72,143.84
Owned After
257,626
Chief Financial Officer
Avg Cost/Share
$19.64
Shares
5,229
Total Value
$102,710.61
Owned After
266,466
SVP, Ops & Adm/Chief Legal Ofr
Avg Cost/Share
$19.67
Shares
3,460
Total Value
$67,896.06
Owned After
304,174
Chief Financial Officer
Avg Cost/Share
$20.15
Shares
18,542
Total Value
$373,539.72
Owned After
266,466
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| RECUPERO ANTHONY J | SIBN | Other | Feb 17, 2026 | Sell | $15.39 | 21,049 | $324,203.85 | 257,626 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Feb 17, 2026 | Sell | $15.37 | 21,528 | $330,981.88 | 266,466 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Feb 17, 2026 | Sell | $15.32 | 93,475 | $1,432,121.59 | 559,729 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Feb 17, 2026 | Sell | $15.35 | 20,756 | $318,642.34 | 304,174 | |
| DUNN JEFFREY W | SIBN | Director | Feb 2, 2026 | Sell | $16.42 | 337 | $5,532.09 | 9,970 | |
| DUNN JEFFREY W | SIBN | Director | Jan 8, 2026 | Sell | $21.28 | 20,000 | $425,506.00 | 9,970 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Jan 2, 2026 | Sell | $19.62 | 3,677 | $72,143.84 | 257,626 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Jan 2, 2026 | Sell | $19.64 | 5,229 | $102,710.61 | 266,466 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Jan 2, 2026 | Sell | $19.67 | 3,460 | $67,896.06 | 304,174 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Dec 18, 2025 | Sell | $20.15 | 18,542 | $373,539.72 | 266,466 |
Compare SIBN vs Leading Stocks
See how SIBN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.